XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss Per Share (Tables)
12 Months Ended
Dec. 31, 2024
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the years ended December 31, 2024 and 2023 are as follows:

 

   Year ended
December 31, 
2024
(Shares)
   Year ended
December 31, 
2023
(Shares)
 
Convertible debt   40,731,757    13,363,993 
Stock options   1,513,335    1,520,002 
Warrants to purchase shares of common stock   22,011,614    10,442,093 
    64,256,706    25,326,088